Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

FromPsychedelics Today


PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

FromPsychedelics Today

ratings:
Length:
64 minutes
Released:
Jun 28, 2022
Format:
Podcast episode

Description

In this episode of the podcast, Joe interviews James Lanthier, the CEO of Mindset Pharma; a biotechnology company discovering and developing new (and hopefully safer, more predictable, and more palatable) psychedelic compounds. www.psychedelicstoday.com
Released:
Jun 28, 2022
Format:
Podcast episode

Titles in the series (100)

A show discussing the important academic and other research in the field of Psychedelics. We discuss how psychedelics relate to human potential and healing.